Showing results (211-220 of 590) with videos related to
Sort By:
Pageof 59
Respiratory Medicine|February 27, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trialsLuca Richeldi, Vincent Cottin, Roland M du Bois, et al.Therapeutic Advances in Musculoskeletal Disease|May 15, 2023
Systemic sclerosis associated interstitial lung disease: a survey of current practices in FranceAmélie Nicolas, Sylvie Leroy, Luc Mouthon, et al.Biology|May 28, 2020
Clinical Genetics of Prolidase Deficiency: An Updated ReviewMarta Spodenkiewicz, Michel Spodenkiewicz, Maureen Cleary, et al.Journal of Comparative Effectiveness Research|December 20, 2022
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2007
Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated associationSophie Dupuis-Girod, Sophie Giraud, Evelyne Decullier, et al.BMJ Open Respiratory Research|July 5, 2022
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosisSteven D Nathan, Jurgen Behr, Vincent Cottin, et al.Chest|May 4, 2019
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary FibrosisMichael Kreuter, David J Lederer, Maria Molina-Molina, et al.BMJ Open Respiratory Research|September 21, 2018
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trialToby M Maher, Tamera J Corte, Aryeh Fischer, et al.Lung|January 9, 2025
Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ONWim A Wuyts, Francesco Bonella, Nazia Chaudhuri, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Acute exacerbations of progressive-fibrosing interstitial lung diseasesMartin Kolb, Benjamin Bondue, Alberto Pesci, et al.Pageof 59